Pressroom: Press Releases


Ludwig Fund Gives $120 Million for Cancer Research

Memorial Sloan Kettering Cancer Center is one of six leading institutions that will share in a $120 million gift from a foundation created by American billionaire Daniel K. Ludwig.

November 14, 2006
Adult Survivors of Childhood Cancer Face Health Issues

Almost three-fourths of pediatric cancer survivors will have a chronic health problem within 30 years after the cancer diagnosis, with 40 percent experiencing a serious, life-threatening, disabling, or fatal condition, according to investigators from Memorial Sloan Kettering Cancer Center (MSKCC), St. Jude Children’s Research Hospital, and other institutions.

October 11, 2006
Estate of Fashion Designer Geoffrey Beene Donates Funds to Memorial Sloan Kettering Cancer Center

A gift from the estate of renowned fashion designer Geoffrey Beene will enable MSKCC to launch an ambitious research initiative to be known as the Geoffrey Beene Cancer Research Center.

September 27, 2006
Long-term Outcomes for Prostate Cancer Show Intensity Modulated Radiation Therapy Curative: 89 Percent of Men Disease-Free Eight Years Later

Results from the largest study of men with prostate cancer treated with high-dose, intensity modulated radiation therapy (IMRT) show that the majority of patients remain alive with no evidence of disease after an average follow-up period of eight years.

September 27, 2006
The Starr Foundation Launches Multi-Institutional Cancer Consortium

The Starr Foundation today announced that it has made a $100 million grant to create a wide-ranging cancer consortium to coordinate the efforts of five internationally renowned research institutions in the fight against cancer. Joining this ambitious undertaking are The Broad Institute of MIT and Harvard, Cold Spring Harbor Laboratory, Memorial Sloan Kettering Cancer Center, The Rockefeller University and Weill Cornell Medical College.

September 21, 2006
New Milestones in Cancer Research and Education at Memorial Sloan Kettering

Memorial Sloan Kettering Cancer Center (MSKCC) is now poised to take greater advantage of a new era in cancer research and education with the opening of a state-of-the-art research center, the establishment of a new graduate school, and the founding of a novel research program in human oncology.

September 18, 2006
Outpatient Cancer Facility Opens in New Jersey

Memorial Sloan Kettering Cancer Center (MSKCC) opened a new state-of-the-art outpatient cancer treatment facility in Basking Ridge, New Jersey, today. The new 85,000-square-foot facility incorporates the latest concepts in therapeutic design and offers the most advanced cancer care services.

September 5, 2006
Radical Surgery for Kidney Cancer Is Risk Factor for Chronic Kidney Disease

A retrospective study by urologists at MSKCC and their colleagues, suggests that this practice needs to be re-evaluated. Researchers add that with advances in imaging, almost 70 percent of kidney cancer patients have their tumor detected at a very small size allowing surgeons to perform less radical surgery with superior results.

September 5, 2006
New Stem Cell Research Grants Announced

The Tri-Institutional Stem Cell Initiative, comprised of three leading New York City biomedical research institutions — Memorial Sloan Kettering Cancer Center, The Rockefeller University, and Weill Medical College of Cornell University — has announced the first wave of stem cell research projects to be funded through a $50 million gift from The Starr Foundation.

July 31, 2006
Peter Scardino Named Chairman of Surgery

Peter Scardino, MD, has been named the new Chairman of the Department of Surgery at Memorial Sloan Kettering Cancer Center.

July 5, 2006
State-of-the-Art Surgical Suites Open

Memorial Sloan Kettering Cancer Center (MSKCC) has opened a new 72,000-square-foot surgical center that was uniquely designed to take advantage of the latest medical technology while enhancing patient safety and efficiency of care.

June 14, 2006
Cancer-Reducing Benefits of Preventive Surgery May Be Specific to Gene Mutation

ATLANTA, June 5, 2006 - A new multicenter study is the first to suggest that the prophylactic removal of the ovaries and fallopian tubes may provide a different benefit for women who carry a genetic mutation in the BRCA2 gene than for those who have a BRCA1 genetic mutation. The results of the study, which are being presented today at the annual American Society of Clinical Oncology meeting, also provide the strongest evidence to date that this surgery significantly reduces the overall risk of BRCA-associated breast and ovarian cancers.

June 5, 2006
Targeted Therapy Shows Significant Benefits Over Standard Treatment for Advanced Kidney Cancer

ATLANTA, June 4, 2006 - According to a new study, the drug sunitinib malate (Sutent®) is more effective than the current standard cytokine treatment given as an initial therapy for patients with advanced kidney cancer, also known as metastatic renal cell carcinoma (mRCC). The study is being presented today at the annual American Society of Clinical Oncology meeting.

June 4, 2006
MSKCC Receives Record Gift of $100 Million from Mortimer B. Zuckerman for Cancer Research Facility

Memorial Sloan Kettering Cancer Center (MSKCC) today announced a major commitment from publisher, real estate developer, and MSKCC Board member Mortimer B. Zuckerman of $100 million from his charitable trust toward Memorial Sloan Kettering’s new cancer research facility, including a 23-story laboratory structure that opens this month. Mr. Zuckerman’s donation is the largest single commitment by an individual in Memorial Sloan Kettering’s history.

May 10, 2006
New York Yankees and Memorial Sloan Kettering Launch Yankees Universe

The New York Yankees and Memorial Sloan Kettering Cancer Center have announced a new and unprecedented initiative to raise funds to help support research and treatment for children with cancer.

April 10, 2006
Protein Regulates Quiescent Blood Stem Cells that Are Linked to Enhanced Recovery from Radiation and Chemotherapy

Scientists have uncovered new information about what orchestrates the complex balance between blood stem cells and mature blood cells, a relationship that is often disrupted in leukemia. The results will lead to a better understanding of the behavior of leukemic cells and may have vital clinical applications for patients recovering from chemotherapy, radiation therapy, or bone marrow transplantation.

March 13, 2006
Chemotherapy Pumped Directly to the Liver Improves Survival for Patients with Colorectal Cancer That Has Spread to the Liver

A multi-institutional study led by Memorial Sloan Kettering Cancer Center (MSKCC) shows that patients whose colorectal cancer has spread to the liver and who received chemotherapy directly to the liver through a pump in the abdomen (an approach called Hepatic Arterial Infusion or HAI) fare better than those who received systemic (intravenously administered) chemotherapy.

February 27, 2006
Underutilized Treatment for Advanced Ovarian Cancer Found to Significantly Improve Survival

Women with Stage III ovarian cancer when treated with a combination of intravenous (IV) and intra-abdominal chemotherapy, following the successful surgical removal of tumors, survived almost a year longer than those who received IV chemotherapy alone.

January 4, 2006


New Computerized Tool Predicts Chance of Breast Cancer's Spread from the Sentinel Lymph Nodes to Axillary Lymph Nodes

Researchers at Memorial Sloan Kettering Cancer Center have developed a new computerized tool called a nomogram that will help patients and their physicians calculate the likelihood of breast cancer spreading beyond the sentinel lymph nodes to additional lymph nodes under the arms (axilla).

December 3, 2003
Risk for Lung Cancer Varies Among Smokers

A new study that shows lung cancer risk varies widely among smokers may help individuals and their doctors decide if voluntary screening is appropriate for them.

March 19, 2003
Syndicate content